Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Researchers and key players are focusing on the development of novel embolization products for the treatment of chronic diseases such as tumor, hemorrhage and others, which is expected to drive growth of the global embolization market over the forecast period.

For instance, in January 2021, MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, received the U.S. Food and Drug Administration approval for its PMA Supplement for the WEB 17 System, a new addition to the WEB Aneurysm Embolization System for the treatment of intracranial wide neck bifurcation aneurysms. The WEB 17 System, is designed with the latest MicroBraid technology, which features a lower profile delivery system compatible with the VIA 17 microcatheter, and includes additional device configurations.

Moreover, in November 2020, Fluidx Medical Technology, a U.S.-based embolic devices manufacturing company, introduced its novel GPX Embolic Device. It is an innovative embolic designed to combine the benefits of other embolics such as coils, particles, and liquids with simplified preparation, delivery, precision, and control leading to durable, long-term occlusions.

The global embolization market is estimated to be valued at US$ 1,433.6 million in 2020 and is expected to exhibit a CAGR of 8.1% over the forecast period (2020-2027).

Figure 1. Global Embolization Market Share (%) in Terms of Value, By Region, 2020

Embolization  | Coherent Market Insights

Increasing incidence of chronic diseases is expected to drive the market growth over the forecast period.

The increasing incidence of chronic diseases such as cancer, cardiovascular diseases, neurovascular diseases, and others is expected to drive growth of the global embolization market over the forecast period.

For instance, according to the World Health Organization statistics published in March 2021, cancer is the second leading cause of deaths globally, and is responsible for about 10 million deaths per year, across the globe, and about one in six deaths is due to cancer. Furthermore, according to the same source, an estimated 9.6 million deaths occurred due to cancer in 2018, globally.

Additionally, according to the Global Burden of Disease (GBD), an article published in the National Center for Biotechnology Information (NCBI) in July 2020, prevalence of ischemic heart disease is increasing. The GBD datasets analyzed that in 2020, the prevalence rate of ischemic heart disease was 1,655 per 100,000 global population, and is expected to exceed 1,845 by 2030.

Moreover, according to the Brain Aneurysm Foundation report 2020, there are almost 500,000 deaths worldwide each year caused by brain aneurysms, and half of the victims are younger than 50 years of age.

request-sample

Embolization Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 1,433.6 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 8.1% 2027 Value Projection: US$ 2,468.7 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Particles (Radioembolization Spheres, Drug-Eluting Beads, Microspheres (or Blands beads, without drug), PVA particles (Polyvinyl Alcohol)), Liquid Embolic, Plugs, Coils
  • By Indication: Hemorrage/Bleeding, Benign Prostatic Hyperplasia (BPH), Uterine Fibroid, Tumor (Malignant, including Liver Cancer), Malformation (AVM, AVF), Venous embolization (incl. Varicocele for ex), Others
  • By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Others
Companies covered:

IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson

Growth Drivers:
  • Increasing novel product launches and approvals
  • Increasing incidence of chronic diseases
Restraints & Challenges:
  • Product recalls
  • Complications associated with embolization

Figure 2. Global Embolization Market Share (%), by Product Type, 2020

Embolization  | Coherent Market Insights

Global Embolization Market– Impact of Coronavirus (Covid-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it as a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus (COVID-19) has resulted in over 122 million infected individuals worldwide, as of March 19, 2021.

The coronavirus or COVID-19 outbreak that started from Wuhan, China has spread across continents, affecting various industries globally. Supply of key materials such as probes required for interventional ablation have been severely disrupted due to forced quarantine, and imposed lockdowns in various countries. This has led to disruption in the link between regional warehouses, the transportation of materials between regions cannot be carried out successfully. This shortage of medical devices such as embolic coils, plugs required for embolization procedures have affected the supply chain of the global embolization market.

Moreover, the hospitals are delaying the uterine fibroid embolization of patients who are stable and the surgery can be postponed, or suggesting patients to undergo the treatment from outpatient’s services, to reduce the high risk of getting infected by the COVID-19.

Global Embolization Market Restraint

Product recall is a voluntary action taken, when laws administered by the U.S. Food and Drug Administration (FDA) are violated by manufacturers and distributors. The action is taken to protect public from the risk of injuries. Increasing number of product recalls of embolization products by various developers/manufacturers is expected to hinder growth of the market.

For instance, in March 2020, Medtronic Plc recalled Pipeline Flex Embolization Device (available in the U.S.) and Pipeline Flex Embolization Device with Shield Technology. The reason behind the recall of these two products is that there is a risk of the delivery system, which will fracture while placing the stent inside the patient. The U.S. FDA received 50 Medical Device Reports, with 10 injuries and one death regarding these embolization products from November 1, 2019 to March 1, 2020.

Key Players

Major players operating in the global embolization market include IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson

Embolization is a minimally invasive treatment procedure that blocks one or more blood vessels or abnormal vascular channels. Embolization procedure requires various types of embolization particles such as radioembolization spheres, drug-eluting beads, microspheres, PVA particles (Polyvinyl Alcohol), and other products such as liquid embolic, plugs, and coils. Embolization procedure is used in the treatment of various chronic diseases such as cancer, uterine fibroid, and other complications of chronic diseases.

Market Dynamics

The academic and research institutes are focusing on the research and development in embolization PVA particles (polyvinyl alcohol), which is expected to drive the market growth over the forecast period

For instance, in April 2019, Washington University School of Medicine, a research university in the U.S., initiated the clinical trial study on Middle Meningeal Artery Embolization with polyvinyl alcohol particles (PVA) on August 2019 and the clinical trial study is expected to be completed by January 1, 2022

Key features of the study:

  • This report provides in-depth analysis of the global embolization market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global embolization market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global embolization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global embolization market

Detailed Segmentation:

  • Global Embolization Market, By Product Type:
    • Particles
      • Radioembolization Spheres
      • Drug-eluting Beads
      • Microspheres (or Blands beads, without drug)
      • PVA particles (Polyvinyl Alcohol)
    • Liquid Embolic
    • Plugs
    • Coils
  • Global Embolization Market, By Indication:
    • Hemorrage/Bleeding
    • Benign Prostatic Hyperplasia (BPH)
    • Uterine Fibroid
    • Tumor (Malignant, including Liver Cancer)
    • Malformation (AVM, AVF)
    • Venous embolization (incl. Varicocele for ex)
    • Others
  • Global Embolization Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Others
  • Global Embolization Market, By Region:
    • North America
      • By Product Type
        • Particles
          • Radioembolization Spheres
          • Drug-eluting Beads
          • Microspheres (or Blands beads, without drug)
          • PVA particles (Polyvinyl Alcohol)
        • Liquid Embolic
        • Plugs
        • Coils
      • By Indication
        • Hemorrage/Bleeding
        • Benign Prostatic Hyperplasia (BPH)
        • Uterine Fibroid
        • Tumor (Malignant, including Liver Cancer)
        • Malformation (AVM, AVF)
        • Venous embolization (incl. Varicocele for ex)
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Product Type
        • Particles
          • Radioembolization Spheres
          • Drug-eluting Beads
          • Microspheres (or Blands beads, without drug)
          • PVA particles (Polyvinyl Alcohol)
        • Liquid Embolic
        • Plugs
        • Coils
      • By Indication
        • Hemorrage/Bleeding
        • Benign Prostatic Hyperplasia (BPH)
        • Uterine Fibroid
        • Tumor (Malignant, including Liver Cancer)
        • Malformation (AVM, AVF)
        • Venous embolization (incl. Varicocele for ex)
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type
        • Particles
          • Radioembolization Spheres
          • Drug-eluting Beads
          • Microspheres (or Blands beads, without drug)
          • PVA particles (Polyvinyl Alcohol)
        • Liquid Embolic
        • Plugs
        • Coils
      • By Indication
        • Hemorrage/Bleeding
        • Benign Prostatic Hyperplasia (BPH)
        • Uterine Fibroid
        • Tumor (Malignant, including Liver Cancer)
        • Malformation (AVM, AVF)
        • Venous embolization (incl. Varicocele for ex)
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type
        • Particles
          • Radioembolization Spheres
          • Drug-eluting Beads
          • Microspheres (or Blands beads, without drug)
          • PVA particles (Polyvinyl Alcohol)
        • Liquid Embolic
        • Plugs
        • Coils
      • By Indication
        • Hemorrage/Bleeding
        • Benign Prostatic Hyperplasia (BPH)
        • Uterine Fibroid
        • Tumor (Malignant, including Liver Cancer)
        • Malformation (AVM, AVF)
        • Venous embolization (incl. Varicocele for ex)
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type
        • Particles
          • Radioembolization Spheres
          • Drug-eluting Beads
          • Microspheres (or Blands beads, without drug)
          • PVA particles (Polyvinyl Alcohol)
        • Liquid Embolic
        • Plugs
        • Coils
      • By Indication
        • Hemorrage/Bleeding
        • Benign Prostatic Hyperplasia (BPH)
        • Uterine Fibroid
        • Tumor (Malignant, including Liver Cancer)
        • Malformation (AVM, AVF)
        • Venous embolization (incl. Varicocele for ex)
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type
        • Particles
          • Radioembolization Spheres
          • Drug-eluting Beads
          • Microspheres (or Blands beads, without drug)
          • PVA particles (Polyvinyl Alcohol)
        • Liquid Embolic
        • Plugs
        • Coils
      • By Indication
        • Hemorrage/Bleeding
        • Benign Prostatic Hyperplasia (BPH)
        • Uterine Fibroid
        • Tumor (Malignant, including Liver Cancer)
        • Malformation (AVM, AVF)
        • Venous embolization (incl. Varicocele for ex)
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • IMBiotechnologies Ltd. *
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • ABK Biomedical Inc.
    • EmboMedics
    • Guerbet
    • Boston Scientific Corporation
    • Medtronic Plc.
    • Varian Medical Systems, Inc.
    • Terumo Corporation
    • Merit Medical Systems, Inc.
    • Cook Group
    • Johnson & Johnson

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Indication
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario
    • Acquisition, Collaboration, and Agreement
    • Epidemiology
    • PEST Analysis
    • Reimbursement Scenario
    • Pricing Analysis, By Procedure
  4. Global Embolization Market – Impact of Coronavirus (Covid-19) Pandemic
    • Government Initiatives
    • Impact on Supply and Demand
    • Clinical Trial Impact Analysis
  5. Global Embolization Market, By Product Type, 2020 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Particles
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Radioembolization Spheres
          • Introduction
          • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Drug-eluting Beads
          • Introduction
          • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Microspheres (or Blands beads, without drug)
          • Introduction
          • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • PVA particles (Polyvinyl Alcohol)
          • Introduction
          • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Liquid Embolic
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Plugs
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Coils
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
  6. Global Embolization Market, By Indication, 2020 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hemorrage/Bleeding
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Benign Prostatic Hyperplasia (BPH)
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Uterine Fibroid
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Tumor (Malignant, incl Liver Cancer)
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Malformation (AVM, AVF)
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Venous embolization (incl. Varicocele for ex)
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
  7. Global Embolization Market, By End User, 2020 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals & Clinics
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Ambulatory Surgery Centers
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
  8. Global Embolization Market, By Region, 2020 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Product Type, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Indication, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By End User, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Country, 2020 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Product Type, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Indication, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By End User, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Country, 2020 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Product Type, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Indication, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By End User, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Country, 2020 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Product Type, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Indication, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By End User, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Country, 2020 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Product Type, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Indication, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By End User, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Country, 2020 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Product Type, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Indication, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By End User, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Country/Region, 2020 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Market Share Analysis
      • IMBiotechnologies Ltd. *
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ABK Biomedical Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • EmboMedics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Guerbet
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic Plc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Varian Medical Systems, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Terumo Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merit Medical Systems, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cook Group
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 206 market data tables and 56 figures on "Embolization Market” - Global forecast to 2027

FAQgrowicon

Frequently Asked Questions

The global embolization market size is estimated to be valued at US$ 1,433.6 million in 2020 and is expected to exhibit a CAGR of 8.1% between 2020 and 2027.
Increasing novel product launches and approvals and increasing incidence of chronic diseases are expected to drive the market growth over the forecast period.
Particles segment is expected to hold the major market share, owing to increasing product approvals and launches during the forecast period.
North America holds the largest market share in the market.
Major factor hampering growth of the market includes product recalls and complications associated with embolization.
Major players operating in the market include IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner